Showing results (381-390 of 696) with videos related to
Sort By:
Pageof 70
Cancer Cell|October 19, 2006
Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignanciesJing Yang, Jianfei Qian, Michele Wezeman, et al.Sleep & Breathing = Schlaf & Atmung|May 11, 2019
Obstructive sleep apnoea predicted by the STOP-BANG questionnaire is not associated with higher rates of post-operative complications among a high-risk surgical cohortAi-Ming Wong, Michael Wang, Daniel J Garner, et al.Journal of Hematology & Oncology|August 29, 2021
The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphomaVivian Changying Jiang, Yang Liu, Alexa Jordan, et al.Communications Medicine|December 30, 2025
Analysis of mucosal immune dysregulation and safety and tolerability of endoscopic topical steroid therapy for long-COVID hyposmia: randomized, double-blinded pilot studySarah Kim, Vincent M D'Anniballe, John B Finlay, et al.Plos One|November 16, 2013
The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational modelsAbimbola A Onasoga-Jarvis, Karin Leiderman, Aaron L Fogelson, et al.Cancer|July 12, 2007
Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastasesMartin Majer, Randy L Jensen, Dennis C Shrieve, et al.Journal of Clinical and Translational Science|November 29, 2023
REAP-2: An interactive quantitative tool for robust and efficient dose-response curve estimationXinying Fang, Xinyi Liu, Vernon M Chinchilli, et al.European Journal of Haematology|April 8, 2020
BAY 81-8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS studyCristina Santoro, Beng Fuh, Phu Quoc Le, et al.Lasers in Surgery and Medicine|January 16, 2024
Novel 40 µm spot size 3050/3200 nm DFG laser versus CO2 laser for laser-assisted drug deliveryParita T Suwan, Ga Ram Ahn, Roger Sumner, et al.Haematologica|September 5, 2024
Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naïve or relapsed/refractory mantle cell lymphoma: phase Ib trialTycel Phillips, Michael Wang, Tadeusz Robak, et al.Pageof 70